Plataforma BIOBADASER III

Registro Español de Acontecimientos Adversos de Terapias Biológicas en Enfermedades Reumáticas

Biobadaser Fase III

Change in the discontinuation pattern of tumour necrosis factor antagonists in rheumatoid arthritis over 10 years: data from the Spanish registry BIOBADASER 2.0.

13/01/2012

Gómez-Reino JJ, Rodríguez-Lozano C, Campos-Fernández C, Montoro M, Descalzo MA, Carmona L; on behalf of the BIOBADASER 2.0 Study Group.

Descargar documento

Ann Rheum Dis. 2011 Oct 13. [Epub ahead of print]